(ARRY) Array Biopharma complete technical analysis [charts+indicators] | Buy/Sell Array Biopharma | (ARRY) share price targets
Complete technical analysis of Array Biopharma (ARRY) by charts plus indicators, forecast predictions and share price targets for Array Biopharma (ARRY)
Array Biopharma trades in USA in Health Care sector.
10 day averaged volume of Array Biopharma is 6134020
| Date | Daily Closing Price | Open | High | Low | Volume |
| 26 Fri Apr 2024 | 12.40 | 11.91 | 13.03 | 11.91 | 0.685 times |
| 25 Thu Apr 2024 | 11.94 | 11.72 | 12.13 | 11.62 | 0.578 times |
| 24 Wed Apr 2024 | 12.23 | 11.87 | 12.28 | 11.60 | 0.884 times |
| 23 Tue Apr 2024 | 11.94 | 11.67 | 12.38 | 11.59 | 0.924 times |
| 22 Mon Apr 2024 | 11.69 | 11.33 | 11.84 | 11.08 | 0.947 times |
| 19 Fri Apr 2024 | 11.27 | 10.87 | 11.30 | 10.83 | 1.338 times |
| 18 Thu Apr 2024 | 10.97 | 11.20 | 11.32 | 10.82 | 1.063 times |
| 17 Wed Apr 2024 | 11.17 | 11.42 | 11.67 | 11.08 | 1.052 times |
| 16 Tue Apr 2024 | 11.40 | 12.00 | 12.05 | 11.25 | 1.355 times |
| 15 Mon Apr 2024 | 12.14 | 12.75 | 12.92 | 12.08 | 0.88 times |
My analysis of stock is bearish for shortterm, and stock might move down till 11.6 or till 10.1. Use a stoploss of 12.92 and if the stock hits stoploss, then it can shoot up till 14.21
Share price targets for Array Biopharma (ARRY)
| Target Type | Value |
| Downside Target | 10.82 |
| Downside Target | 11.08 |
| Downside Target | 11.38 |
| Upside Target | 12.52 |
| Upside Target | 12.81 |
| Upside Target | 13.49 |
| Upside Target | 14.71 |
| Upside Target | 15.12 |
| Upside Target | 15.28 |
| Upside Target | 15.35 |
| Upside Target | 16.22 |
| Upside Target | 17.76 |
| Upside Target | 20.15 |
Intraday share price targets for Array Biopharma (ARRY)
| Target Type | Value |
| Downside Intraday Target | 11.31 |
| Downside Intraday Target | 10.22 |
| Upside Intraday Target | 13.26 |
| Upside Intraday Target | 14.12 |
| Downside Intraday Target | 12.17 |
Weekly technical analysis of Array Biopharma (ARRY)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 26 Fri Apr 2024 | 12.40 | 11.33 | 13.03 | 11.08 | 0.706 times |
| 19 Fri Apr 2024 | 11.27 | 12.75 | 12.92 | 10.82 | 1.756 times |
| 12 Fri Apr 2024 | 12.94 | 14.01 | 14.71 | 12.86 | 0.792 times |
| 05 Fri Apr 2024 | 13.80 | 15.02 | 15.12 | 13.72 | 1.212 times |
| 28 Thu Mar 2024 | 14.91 | 13.62 | 15.35 | 13.49 | 0.6 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Array Biopharma (ARRY)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 26 Fri Apr 2024 | 12.40 | 15.02 | 15.12 | 10.82 | 0.912 times |
| 28 Thu Mar 2024 | 14.91 | 13.68 | 15.35 | 11.38 | 0.868 times |
| 29 Thu Feb 2024 | 13.64 | 14.12 | 16.22 | 12.81 | 1.109 times |
| 31 Wed Jan 2024 | 13.24 | 16.54 | 17.76 | 12.52 | 0.998 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Array Biopharma (ARRY)
Price action analysis of Array Biopharma ( (ARRY) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Array Biopharma ( (ARRY) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Array Biopharma ( (ARRY) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Array Biopharma ( (ARRY) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Array Biopharma stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Array Biopharma in short term and the sell signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Array Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Array Biopharma in short term and BUY signal is strong.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Array Biopharma is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 11.64 and Array Biopharma (ARRY) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Array Biopharma (ARRY) stock. Volume based technical analysis of Array Biopharma (ARRY) stock is negative.
Array Biopharma Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Array Biopharma ( (ARRY) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Array Biopharma ( (ARRY) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Array Biopharma ( (ARRY) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Array Biopharma ( (ARRY) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Array Biopharma stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Array Biopharma in short term and the sell signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Array Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Array Biopharma in short term and BUY signal is strong.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Array Biopharma is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 11.64 and Array Biopharma (ARRY) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Array Biopharma (ARRY) stock. Volume based technical analysis of Array Biopharma (ARRY) stock is negative.
Array Biopharma Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.